Stay updated on PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.

Latest updates to the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page
- Check5 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the study history.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision v3.4.3 was added to the study record history and Revision v3.4.2 was removed.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedAdded revision: v3.4.2 to the history and removed revision v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedThe new screenshot shows a revision label 'Revision: v3.4.1' while the old screenshot shows 'Revision: v3.4.0', reflecting a minor update to the page's version history.SummaryDifference0.1%

- Check55 days agoChange DetectedThe history page introduces a glossary option and adds green and red highlights to show additions and deletions. It also displays a new Revision: v3.4.0 label and updates the No FEAR Act Data capitalization.SummaryDifference1.0%

- Check70 days agoChange DetectedA new 'Study Status' section has been added to the page to display the current status of the study and related updates.SummaryDifference0.5%

Stay in the know with updates to PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.